(Q33377209)

English

Optimal ex vivo expansion of neutrophils from PBSC CD34+ cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Optimal ex vivo expansion of neutrophils from PBSC CD34+ cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO (English)

1 reference

Europe PubMed Central

26 July 2017

author name string

Olga Tura

1

1 reference

Europe PubMed Central

26 July 2017

G Robin Barclay

2

1 reference

Europe PubMed Central

26 July 2017

Huw Roddie

3

1 reference

Europe PubMed Central

26 July 2017

John Davies

4

1 reference

Europe PubMed Central

26 July 2017

Marc L Turner

5

1 reference

Europe PubMed Central

26 July 2017

publication date

30 October 2007

1 reference

Europe PubMed Central

26 July 2017

Journal of Translational Medicine

1 reference

Europe PubMed Central

26 July 2017

5

1 reference

Europe PubMed Central

26 July 2017

53

1 reference

Europe PubMed Central

26 July 2017

https://scigraph.springernature.com/pub.10.1186/1479-5876-5-53

0 references

Ex vivo expansion of umbilical cord blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Granulocyte transfusion: revisited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and effic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Ex vivo expansion of hematopoietic stem cells by cytokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Optimizing hematopoietic recovery following bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Granulocyte transfusion: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Influence of medium components on ex vivo megakaryocyte expansion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Ex vivo expansion of hematopoietic progenitor cells and mature cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Rebirth of granulocyte transfusions: should it involve pediatric oncology and transplant patients?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

21 June 2018

A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

31 October 2018

Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

31 October 2018

Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

31 October 2018

Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

31 October 2018

Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

31 October 2018

Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174439

31 October 2018

Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ex vivo expansion of mature human neutrophils with normal functions from purified peripheral blood CD34+ haematopoietic progenitor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood stem cell transplantation in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of ex vivo expanded cord blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additional transplantation of ex vivo generated megakaryocytic cells after high-dose chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ex vivo expansion of hematopoietic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBT

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17971220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1479-5876-5-53

1 reference

Europe PubMed Central

26 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1479-5876-5-53

9 September 2019

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33377209&oldid=1629058280"